The Problem with America’s Lab Mice [video]
youtube.com
youtube.com
These brothers are smart and often interesting but they are also both audibly quite taken with their own brilliance and often not what I want to listen to.
Drugs that have been developed using these mice could have a higher toxicity than the lab mice data suggests. Weinstein uses the Vioxx scandal as a possible example of such a drug.
Eric Weinstein's 2hr+ Portal Podcast #19 on YouTube is frustrating but I'd summarize the "new" info from memory as:
- math oriented older brother Eric thinks biology oriented younger brother Bret is Nobel Prize worthy
- yet Bret and his mouse telomere paper live in obscurity
- reason 1: Bret chose Evergreen rather than a top tier University
- reason 2: the science establishment is biased against disruptive ideas and scientists
- Carol Greider’s 2009 Nobel Prize was based on work inspired by informal phone calls and emails from Bret
- Bret claims that Greider failed to recognize his contribution and then actively undermined his paper(s) through the peer review process
I wish we had TL;DR + Start/Stop Links into the original video. Long form audio/video podcasts are both a boon and a curse since the content cannot easily be searched or linked to.
Bret is quick to point out that Dr. Greider's Nobel prize is well deserved and for related, but earlier work. The contention is over later work.
Their conversation did inspire these findings about lab mice telomeres. But Dr. Greider's lab decided to keep the information "in house". This means that instead of publishing the source of the information, they can use their knowledge to start predicting other results, and publish a full stream of paper first. This is at 1:23:50.
She discovered telomerase in 1984 and had decades of research on it. She didn't win the prize from a phone call with Bret.
Neuroscience is a hard problem no doubt, but I also think the current paradigm for how basic neuroscience research is done is way too limited, and that is impacting the viability of potential treatments that make it to clinical trial phase.
Our current paradigm is optimized to avoid injuring humans at all costs, including to the extent that it diminishes the chance of success.
By advocating for a different model, we're stating "Avoiding injuring humans in drug discovery is not our primary concern."
Maybe that's worth it in a broader calculation, but let's be honest about what we're talking about.
Pharma companies and regulatory bodies don't put in place billion+ dollar trial hoops on a whim: they do so to avoid permanently injuring or killing people with some pretty horrific side effects, to the extent we can.
But also I was talking about basic neuroscience. The pharma companies don't just magically start a clinical trial, as you said. They base the clinical trials on previous results from academia and their own basic research labs. Which mostly doesn't involve humans at all. Perhaps those labs are not putting forward the best candidates, or not doing as good a job as they could be at eliminating candidates.
I would characterize it as more avoiding the liability of injury to humans than avoiding injury overall (edit: and by liability i'm not just talking legal liability, there are also emotional consequences a person would experience if someone dies or is gravely injured as part of their medical research). A family member died of cancer this year. Nobody is liable for her 'injury' because there's no evidence it wasn't a natural occurrence and standard of care was followed in her treatment. However, a number of plausibly beneficial alternatives or adjuncts to that standard were in phase 3 trials that either her doctor flat out refused to consider or that she was ineligible for...not due to concerns of clinical efficacy of the treatment, but due to prior treatments that could have smeared the signal in the results (this is particularly true for immunotherapy trials).
It's a medical version of the trolly problem and from what I can see and definitely in our experience doctors choose to ride the rails they were set on. I don't blame them either. With the current climate in medicine a wrong move could end their career and possibly prevent them from helping those in the future.
It's an extremely tricky situation and I empathize with those that are faced with these dilemmas every day at the office. I just don't buy the story that changing our current approach is somehow de-prioritizing injury avoidance.
Nobody in this entire comment section that I have seen so far is advocating for harming more people more frequently in the name of progress. Just because people are asking "are there any other ways of testing drugs" and the current testing system cares about safety does not mean that these people want to abandon safety in order to more cheaply test drugs. Maybe we can find some other way to test drugs that is cheaper per useful drug than the current system and equivalent or better in terms of safety to humans.
> Maybe we can find some other way to test drugs that is cheaper per useful drug than the current system and equivalent or better in terms of safety to humans.
Maybe. But we should start at a place of shared understanding.
HN is notorious for "if they just"isms with regards to other fields.
Consequently, I think it's fair to point out that the thing that most people are lamenting (strict adherence to standards, extremely conservative trial progression) are attached to a value (avoiding harm to humans).
If people are advocating to upend the apple cart, then they don't just get to say "We want to continue to prioritize safety and also not do some things that increase safety."
Personally? I'd be fine with an informed consent alternative that helped speed through population-targeted or riskier drugs. Better to have options. But implementing that system would have costs.
Who is saying this? Simply stating that a system is imperfect is not advocating abolishment (current social issues notwithstanding...), it's an invitation to explore other solutions.
someone: X is imperfect and has unsatisfactory outcomes
you: X implies Y, how dare you hate Y?
> By advocating for a different model, we're stating "Avoiding injuring humans in drug discovery is not our primary concern."I don't know if you can see that your argument is a claim that safety can only exist iff we keep the current system unaltered. That there is no other system conceivable which could do better. Which is clearly absurd.
Now just because we have a bunch of pure-bred homozygous mice doesn't mean mice behave the same way as humans with respect to e.g. metabolic pathways, immune system etc. It's just that we often don't have better models.
The supply of lab mice can be corrected to have a more natural telomere length. All past studies that used mouse models to study the impact of drugs are skewed to under report toxicity and over report carcinogenicity.
> All past studies that used mouse models to study the impact of drugs are skewed to under report toxicity and over report carcinogenicity.
Could the data from long telomere mice be de-skewed to compensate for new-understood effects the long telomeres?
Controls are great, and it makes perfect sense to have studies that produce these extremely well controlled results. But controlling does have its own tradeoffs in practice, as results may very well not be robust/not generalize to things we care about. My problem is that the entire system operates under essentially the same paradigm, so we have very little work trying to address these downsides.
There are enough confounding, uncontrollable variables in biology already.
Btw, in these cases where they find a result seems to only apply to a particular mouse strain, that feels like a pretty trash result to me too. What are we supposed to do with that knowledge? Currently what we often do is build on it, cite it completely out of context, and happily walk away with a publication.
[1]https://www.wired.com/2016/07/science-huge-diversity-problem... [2]https://youtu.be/FHl0nIdbiLA
I haven't seen anyone who is supposed to be solving this issue to be taking any steps towards improving the situation.
Respective agencies acknowledged it but (at least not to my knowledge) didn't follow up on that.
Every animal model is imperfect and the various tools to try to address them (e.g. greater genetic uniformity) have consequences as well.
If you pick the wrong model your research will fail. Even if it gets through the pure research phase, the FDA will want justification as for why your animal of choice is appropriate.
I had a program that required — ugh — guinea pigs. Those suckers ended up costing $1K when all was said and done (not the cost of acquiring them,but looking after them and running the program). Rats would have been cheaper and mice even more but theOr immune systems could reject the pathogen we were trying to treat; the GP was the least expensive animal it would attack. (There turned out to be other advantages too but that was that for research). And when it came time for the preclinical work for IND submission the agency wanted an EMEA more expensive animal because it was a better human model.
So it’s an engineering trade off, just like any other. One controlled for when possible. Sorry there’s no conspiracy.
Here's another example from a while back:
https://news.ycombinator.com/item?id=21911225 - "How an Alzheimer’s ‘cabal’ thwarted progress toward a cure"
When you've got enough incentive, it's hard to resist the urge to use your power to simply decide what is and is not allowed to be true.
While this does happen, science at least allows the possibility of enough evidence to force people into accepting the new model. Without science, many more things are considered untouchable dogma and there is no method to challenge that.
Scientists are still human and make dumb ego driven mistakes, science still provides the best theory out there.
https://grants.nih.gov/grants/guide/pa-files/PAR-19-369.html
Certainly if we hold these kind of ethics we've got no excuses if an advanced alien race wants to use us in their medical experiments.
If an advanced alien wants to use us in experiments, I doubt they'd care much about what we say on the matter. And for all we know, the aliens might come from a predator background and only consider vicious species as true equals.
It's not even comparable.
I do agree that lab animals aren't a resource in themselves – they're just the currently "next best" model to test in before trying a drug out in humans. In fact, mice are actually quite expensive in terms of time and money – custom-genotype mice can cost hundreds of dollars each, and that's just the up-front purchase price. The overhead of maintaining a mouse line is also quite high, with a huge loss incurred for accidental death or euthanization before they've been used as a model. When many research facilities were first shut down due to COVID lockdown this year, I heard that many labs at my university had to euthanize all their mice as they wouldn't be able to care for them. This represents a loss of months of research time and possibly thousands to tens of thousands of research dollars.
Another thing to consider is that many drug candidates that make it to the animal testing stage don't succeed with safety and/or efficacy testing. According to the FDA, 92% of pre-clinical animal tests actually fail to predict drug effectiveness in humans. This highlights a pressing need for other fail-fast/fail-cheap methods that should precede animal testing, like cell culture methods that could be used as a pre-animal screen.
Thank you for the insightful comment, I'll cite the part that is relevant, since my (very serious) point was indeed that by this logic a more "advanced" being than us would have (by our own morals) the right to conduct medical experiments on us humans, because we are capable of feeling less pain.
I think it is in part a symptom of the cost of research causing labs to be centered moreso around a methodology than a question. Having some labs like this isn't a problem, but when an entire field starts to trend this way, and almost everything that gets funding chooses a particular side of a tradeoff (that isn't super well quantified to begin with), then I think we could end up missing a lot.
There are tons of mouse labs, however some have specialized mice or mouse systems. There are also other labs that specialize in other animal systems. These systems are nontrivial to switch between for many reasons, which I think you acknowledge. It is useful for the field in general to have access to the results of a variety of research tools that every individual wouldn't necessarily have access to.
If you do a quick head count of people who know about this effect in 12 months it may well turn out most of them learned it from YouTube.
Isn’t his claim that the lab mice adopted to some change in telomeres that significantly distorted the results of tests? I guess famous intellectuals with PhD aren’t credible sources but Eric Weinstein said that for over a decade they tried to get publicity for the story but ran into resistance.
Poor GP.
This reminds me of people complaining about others taking financial advice from reddit, ignoring that on average the financial advice you get from finance subs there is probably much better than the advice you get asking random friends and family -- which is a common practice.
> Weinstein, Bret S; Ciszek, Deborah (2002). "The reserve-capacity hypothesis: Evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair". Experimental Gerontology. 37 (5): 615–27.
There doesn’t seem to be a succinct write up on how this hypothesis led to Carol Greider’s 2009 Nobel Prize [4]. Greider did not recognize Weinstein’s contribution [5].
[1] https://en.m.wikipedia.org/wiki/Bret_Weinstein#Publications
[2] https://doi.org/10.1016%2FS0531-5565%2802%2900012-8
[3] https://pubmed.ncbi.nlm.nih.gov/11909679
[4] https://www.nobelprize.org/prizes/medicine/2009/illustrated-...